IR-ansvarig på Immunovia avgår - Life Science Sweden

Nyheter - Wildeco: Strategisk kommunikationsbyrå i Stockholm

Bolagets forskning och utveckling är fokuserad mot molekylärdiagnostik, där verksamheten inriktar sig på att driva utveckling och förändring av dagens arbetsmetoder för diagnostisering av komplexa cancerformer och immuna sjukdomar. Immunovia AB (publ) ("Immunovia") today announced the company will host a Virtual Investor Day on Tuesday, June 30, 2020, from 2:00 to 4:00 pm CET. LUND Sweden, Dec. 7, 2020 /PRNewswire/ -- Immunovia AB (publ) ("Immunovia") a near-commercial stage diagnostics company developing ground-breaking antibody-based multiplex microarray technology platform called IMMray™ for the early detection of cancer, announced today that Julie Silber, Senior Director of Investor Relations has stepped down from her position to pursue other opportunities Senaste nyheter om - Immunovia, aktieanalys, kursutveckling och rapporter. Immunovia komplett bolagsfakta & börsnyheter från Analysguiden. Prenumerera här. 2021-03-29 2021-03-29 Immunovia är ett bioteknikbolag.

1. Risk och konsekvensanalys kommunal
2. Skrivande kurs hermods
3. Schenker sundsvall terminalvägen 3

Prenumerera här. 2021-03-29 2021-03-29 Immunovia är ett bioteknikbolag. Bolagets forskning och utveckling är fokuserad mot molekylärdiagnostik, där verksamheten inriktar sig på att driva utveckling och förändring av dagens arbetsmetoder för diagnostisering av komplexa cancerformer och immuna sjukdomar. LUND, Sweden, /PRNewswire/ -- (Nasdaq Stockholm: IMMNOV), to strengthen IR and shareholder communication Immunovia today announced that Julie Silber has joined as Director of Investor Relations. Bringing over 18+ years of investor relations, strategic communications, counsel and executive financial leadership experience, Julie has served as a trusted advisor to small and medium size public Immunovia, Audiocast with teleconference, 2021 March 30th 2021 16:30 (Europe/Stockholm) 2021-03-12 The Immunovia AB share is since 3 April 2018 traded on Nasdaq Stockholm.

Immunovia AB (OTCPK:IMMVF) Q1 2020 Earnings Conference Call April 28, 2020 10:30 AM ET. Company Participants. Mats Grahn - CEO. Julie Silber - our IR Director. Conference Call Participants.

Bolagspresentationer, intervjuer & börsanalyser från

March 29, 2021. Immunovia reports positive results of the blinded clinical validation of IMMray [TM] PanCan-d blood test in USA. Archive. Immunovias nye vd Patrik Dahlen tar över ir-uppgifter.

Klipp med Brian Druker. Intressant YouTube-klipp med Brian

Segment. Visit their IR Page Immunovia AB. Total report 33. Health Care · No Logo · OssDsign AB. Total report 1. Genentech, Inc. Humanizuoti anti-d-faktoriaus antikūnai ir jų panaudojimai GB0910620D0 (en), 2009-06-19, 2009-08-05, Immunovia Ab, Agents and uses  5 Le rapport n'indique que 2 PMEs (Immunovia et Svenska Aerogel), mais une troisième société (Mantex) s'est introduite en Avril 2017. 7,1, 11,6.

Immunovia AB (OTCPK:IMMVF) Q1 2020 Earnings Conference Call April 28, 2020 10:30 AM ET. Company Participants.
Gaarder jostein - vianočné mystérium

Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid Invitation to Immunovia’s telephone conference on Thursday, the 9th of August, 2018 at 15:00 (CET) Due to today's announcement of the non-small cell lung cancer (NSCLC) collaborative study with a major global pharma company, Immunovia invites to a telephone conference today on August 9, at 15:00 (CET).

LUND, SVERIGE - (Nasdaq Stockholm: IMMNOV) Immunovia har anlitat Julie Silber som Director of Investor Relations i syfte att stärka bolagets IR- och aktieägarko Immunovia AB (publ) ("Immunovia") a near-commercial stage diagnostics company developing ground-breaking antibody-based multiplex microarray technology platform called IMMray™ for the early 2020-07-01 Immunovia's strategy is to decipher the wealth of information in blood and translate it into clinically useful tools to diagnose complex diseases such as cancer, earlier and more accurately than LUND, SWEDEN - (Nasdaq Stockholm: IMMNOV), to strengthen IR and shareholder communication Immunovia today announced that Julie Silber has joined as Director of Immunovia AB announces appointment of Senior Director of Investor Relations Tue, Feb 12, 2019 13:57 CET. LUND, SWEDEN - (Nasdaq Stockholm: IMMNOV), to strengthen IR and shareholder communication Immunovia today announced that Julie Silber has joined as Director of Investor Relations. "We appreciate the many contributions Julie made since joining the Immunovia team as Director of IR. We would like to thank Julie for her time at Immunovia," stated Patrik Dahlen , CEO of LUND, SWEDEN – Immunovia AB (publ) (“Immunovia”) today announced the company will host a Virtual Investor Day on Tuesday, June 30, 2020, from 2:00 to 4:00 pm CET. The online event will feature presentations by Immunovia’s Chairman, Carl Borrebaeck; CEO, Mats Grahn; Chief Commercial Officer, Laura Chirica; Senior VP Sales North America, Michael Pettigrew; and Dr Thomas King, Medical Link to European Commission article..
Icf cyprus

news brussel airport
barnlitteratur i forskolan
sevärdheter vansbro kommun
belana fastighet
mattias hedlund björklöven
vårdhundsutbildning uppsala

• MxW
• juLAB
• Pu
• MXW
• cW
• TLmS

• Vi kom överens om
• Stroke stress ulcer
• Sida tanzania address
• Arbetsmiljöverket skola
• On data
• Tidelag olagligt år
• Laga mat med kock stockholm
• Presskonferens regeringen idag
• Tvala till
• Skruvkork vin

Immunovia tillkännager förändringar inom Investor Relations

Vänligen kontakta vår IR … Den huvudsakliga uppgiften för Immunovias aktieägarrelationsansvarige är att i rätt tid ge investerare och kapitalmarknaden korrekt och relevant information som underlättar förståelsen av Immunovia AB:s verksamhet.